SEC Filing Summary: Know Labs, Inc. (KNW)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Know Labs, Inc. on December 18, 2024, covering events occurring on December 17, 2024. The company is incorporated in Nevada and trades on the NYSE American LLC under the symbol KNW.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on a corporate governance action regarding warrant agreements.
Material Changes
The primary material change reported is the amendment of an Extension of Warrant Agreement with Clayton Struve. The company extended the expiration dates of four existing warrant classes by five years, moving them from 2025 to 2030. The number of shares and exercise prices remained unchanged.
| Warrant Issue Date | Shares | Exercise Price | Original Expiration | New Expiration |
|---|---|---|---|---|
| 08-14-2017 | 1,440,000 | $0.25 | 08-13-2025 | 08-13-2030 |
| 12-12-2017 | 1,200,000 | $0.25 | 12-11-2025 | 12-11-2030 |
| 08-04-2016 | 1,785,715 | $0.25 | 08-04-2025 | 08-04-2030 |
| 02-28-2018 | 1,344,000 | $0.25 | 02-28-2025 | 02-28-2030 |
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. The document is a procedural disclosure of the warrant extension agreement.
Investor Verification Checklist
- Verify the total potential dilution from the 5,769,715 warrants now exercisable through 2030.
- Confirm the current market price of KNW stock relative to the $0.25 exercise price to assess immediate dilution risk.
- Review the full text of Exhibit 10.1 (Extension of Warrant Agreement) for any additional covenants or conditions not summarized here.
- Check recent 10-Q or 10-K filings for the company's current cash position and ability to manage potential warrant exercises.